| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/22/2013 | EP2594581A2 Peptide vaccines with Seq Id No: 178, 174, 186 or 194 for cancers expressing tumor-associated antigens |
| 05/22/2013 | EP2594579A1 Truncated human papillomavirus type 58 l1 protein |
| 05/22/2013 | EP2594578A1 Replikin peptides directed against pathogenic infections of invertebrates in aquaculture |
| 05/22/2013 | EP2594288A1 Lyophilized therapeutic peptibody formulations |
| 05/22/2013 | EP2594287A1 Lyophilized therapeutic peptibody formulations |
| 05/22/2013 | EP2594286A1 Lyophilized therapeutic peptibody formulations |
| 05/22/2013 | EP2594285A1 Lyophilized therapeutic peptibody formulations |
| 05/22/2013 | EP2594284A1 Lyophilized therapeutic peptibody formulations |
| 05/22/2013 | EP2594280A1 Activin neutralisers and uses thereof for treatment of diseases associated with aberrant "host defence response" activation |
| 05/22/2013 | EP2594274A1 Novel hyaluronic acid decomposition-promoting factor and inhibitor thereof |
| 05/22/2013 | EP2593789A1 Use of anti-plac1 protein antibodies as biomarkers of infertility, diagnostic kit for the detection of the immune response against plac1 and use of plac1 protein in therapeutic and contraceptive fields |
| 05/22/2013 | EP2593548A1 Human papillomavirus e7 antigen compositions and uses thereof |
| 05/22/2013 | EP2593482A2 A combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system |
| 05/22/2013 | EP2593479A1 Superior efficacy of cd37 antibodies in cll blood samples |
| 05/22/2013 | EP2593476A2 Modified single domain antigen binding molecules and uses thereof |
| 05/22/2013 | EP2593475A2 Anti-addl monoclonal antibody and uses thereof |
| 05/22/2013 | EP2593474A2 Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases |
| 05/22/2013 | EP2593467A1 Carbohydrate hapten-based anti-cancer vaccines and antibody drugs |
| 05/22/2013 | EP2593139A2 Administration of hypoxia activated prodrugs and antiangiogenic agents for the treatment of cancer |
| 05/22/2013 | EP2593138A2 Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract |
| 05/22/2013 | EP2593137A1 Stabilized formulations containing anti-ngf antibodies |
| 05/22/2013 | EP2593136A1 Live attenuated parvovirus |
| 05/22/2013 | EP2593135A1 Modified viral strains, and method for improving the production of vaccine seeds of the influenza virus |
| 05/22/2013 | EP2593134A1 Protective vaccine based on staphylococcus aureus protein sa2412 |
| 05/22/2013 | EP2593133A1 Staphylococcus aureus surface protein sa1789 and protective vaccine based thereon |
| 05/22/2013 | EP2593132A2 METHOD FOR PRODUCING TOXOIDS USING ALPHA - DICARBONYL COMPOUNDS& xA; |
| 05/22/2013 | EP2593126A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases |
| 05/22/2013 | EP2593125A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases |
| 05/22/2013 | EP2593124A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-trna synthetases |
| 05/22/2013 | EP2593121A2 THE cAMP/PKA/HDAC5 PATHWAY AND USES THEREOF |
| 05/22/2013 | CN1643143B Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 05/22/2013 | CN103119168A Human papillomavirus E7 antigen compositions and uses thereof |
| 05/22/2013 | CN103119066A Compound having activity for inhibiting tgf- belta receptor activation, method for screening same, and composition for prevention or treatment of hepatitis c virus-induced diseases |
| 05/22/2013 | CN103119062A Modified single domain antigen binding molecules and uses thereof |
| 05/22/2013 | CN103119061A A method of treating attention deficit hyperactivity disorder |
| 05/22/2013 | CN103119060A A method of treating alzheimer's disease |
| 05/22/2013 | CN103119054A VISTA regulatory T cell mediator protein, VISTA binding agents and use thereof |
| 05/22/2013 | CN103118706A Anti-CD38 antibody and lenalidomide or bortezomib for the treatment of multiple myeloma and NHL |
| 05/22/2013 | CN103118705A Concentrated human immunoglobulin composition |
| 05/22/2013 | CN103118704A Modified viral strains, and method for improving the production of vaccine seeds of the influenza virus |
| 05/22/2013 | CN103118703A Recombinant mycobacterium as vaccine for use in humans |
| 05/22/2013 | CN103118702A Therapeutic vaccination against active tuberculosis |
| 05/22/2013 | CN103118701A OSPA chimeras and use thereof in vaccines |
| 05/22/2013 | CN103118700A Synthetic nanocarrier combination vaccines |
| 05/22/2013 | CN103118696A Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of tryptophanyl tRNA synthetases |
| 05/22/2013 | CN103118695A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases |
| 05/22/2013 | CN103118694A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-tRNA synthetases |
| 05/22/2013 | CN103118693A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl tRNA synthetases |
| 05/22/2013 | CN103118692A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase |
| 05/22/2013 | CN103114095A Trichina AN1 type zinc finger protein-2B recombinant protein antigen and preparation method thereof |
| 05/22/2013 | CN103113458A Hepatitis c virus B-cell epitope peptide PUHI34 and application thereof |
| 05/22/2013 | CN103110945A Application of mononuclear cell antibody in treating inflammation-related tristimania |
| 05/22/2013 | CN103110944A Methods of administering anti-TNF alpha antibodies |
| 05/22/2013 | CN103110943A Novel vaccine adjuvant capable of replacing aluminum hydroxide |
| 05/22/2013 | CN103110942A Preparation method of inactivated newcastle disease vaccine |
| 05/22/2013 | CN103110941A Novel immunological adjuvant and quick immunization scheme |
| 05/22/2013 | CN103110940A Click-chemistry-based pneumococcal polysaccharide conjugate vaccine and preparation method thereof |
| 05/22/2013 | CN103110939A Vaccine for inducing specific immunity of tumor and application thereof |
| 05/22/2013 | CN103110591A 固体灭活疫苗 Solid inactivated vaccine |
| 05/22/2013 | CN103110583A Preparation technology of mycoplasma ovipneumoniae inactivated vaccine |
| 05/22/2013 | CN102352345B Preparation method of newcastle disease HI antigen |
| 05/22/2013 | CN102292432B Mycoplasma gallisepticum formulation |
| 05/22/2013 | CN102205118B Biological product and preparation method thereof |
| 05/22/2013 | CN102145166B Infectious bursal disease VP2 subunit vaccine of recombinant avian influenza M2e, construction method of vaccine and use of vaccine |
| 05/22/2013 | CN102120028B Method for extracting lipopolysaccharides from avian pasteurella multocida and preparing lipopolysaccharide vaccine |
| 05/22/2013 | CN101849006B Improved antibody molecule |
| 05/22/2013 | CN101553251B Immunisation method against the 4 dengue serotypes |
| 05/22/2013 | CN101469019B Cellular membrane protein DERLIN-1, preparation and use thereof |
| 05/22/2013 | CN101456912B Anti P selectin single-chain antibody and use thereof |
| 05/22/2013 | CN101330926B Influenza vaccines extemporaneously adsorbed to aluminium adjuvants |
| 05/22/2013 | CN101300273B TRAIL recipient 2 Polypeptides and antibodies |
| 05/22/2013 | CN101189254B 疫苗 Vaccine |
| 05/22/2013 | CN101124014B Mucosal immunogenic substances comprising a polyinosinic acid - polycytidylic acid based adjuvant |
| 05/21/2013 | US8445660 Chimeric vaccines |
| 05/21/2013 | US8445650 Mutant botulinum neurotoxin serotype A polypeptide and uses thereof |
| 05/21/2013 | US8445646 Therapeutic use of anti-CS1 antibodies |
| 05/21/2013 | US8445645 Identification and engineering of antibodies with variant Fc regions and methods of using same |
| 05/21/2013 | US8445644 ErbB interface peptidomimetics and methods of use thereof |
| 05/21/2013 | US8445449 Method and peptide for regulating cellular activity |
| 05/21/2013 | US8445444 Compositions and methods for diagnosing, treating, and preventing prostate conditions |
| 05/21/2013 | US8445434 IGF-1 fusion polypeptides and therapeutic uses thereof |
| 05/21/2013 | US8445268 Her-2/neu DNA vaccine having anti-cancer activity |
| 05/21/2013 | US8445234 Methods of making VEGF-D polypeptides |
| 05/21/2013 | US8445001 Peptides protective against S. pneumoniae and compositions, methods and uses relating thereto |
| 05/21/2013 | US8445000 Immunogenic compositions of Staphylococcus epidermidis polypeptide antigens |
| 05/21/2013 | US8444998 Probiotic strain and antimicrobial peptide derived therefrom |
| 05/21/2013 | US8444996 Multicomponent vaccine for malaria providing long-lasting immune responses against plasmodia |
| 05/21/2013 | US8444995 Peptide sequences and compositions |
| 05/21/2013 | US8444994 Multivalent antihelminthic vaccine |
| 05/21/2013 | US8444993 Multi-phase emulsions based on amphiphilic block copolymers |
| 05/21/2013 | US8444992 Multiple vaccination including serogroup C meningococcus |
| 05/21/2013 | US8444991 Method of preparing an immunologically-active adjuvant-bound dried vaccine composition |
| 05/21/2013 | US8444990 Antibody-induced apoptosis |
| 05/21/2013 | US8444989 One dose vaccination against mycoplasma infections of pigs |
| 05/21/2013 | US8444988 Cancer treatment method |
| 05/21/2013 | US8444987 Compositions and methods for the diagnosis and treatment of immune disorders |
| 05/21/2013 | US8444986 Monoclonal antibodies specific to hemagglutinin from influenza virus H5-subtype and uses thereof |
| 05/21/2013 | US8444985 Vaccine compositions and methods for treatment of mucormycosis and other fungal diseases |
| 05/21/2013 | US8444984 TNFα-neutralizing antibodies |
| 05/21/2013 | US8444983 Composition of anti-ENDO180 antibodies and methods of use for the treatment of cancer and fibrotic diseases |